Hollow Brook Wealth Management LLC Gilead Sciences, Inc. Transaction History

Hollow Brook Wealth Management LLC

$339 Million
Q2 2025

A detailed history of Hollow Brook Wealth Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Hollow Brook Wealth Management LLC holds 4,434 shares of GILD stock, worth $531,148. This represents 0.15% of its overall portfolio holdings.

Number of Shares

4,434

Previous 4,434 -0.0%

Holding current value

$531,148

Previous $496,000 1.01%

% of portfolio

0.15%

Previous 0.15%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $55,536 - $70,047	834 Added 23.17%	4,434 $371,000
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $1.69 Million - $2.12 Million	-29,194 Reduced 89.02%	3,600 $214,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $6,617 - $7,511	102 Added 0.31%	32,794 $2.38 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $25,586 - $27,605	-378 Reduced 1.14%	32,692 $2.28 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $15,994 - $17,476	-252 Reduced 0.76%	33,070 $2.28 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $1.48 Million - $1.69 Million	-24,749 Reduced 42.62%	33,322 $2.15 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $127,009 - $144,721	-2,242 Reduced 3.72%	58,071 $3.38 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $16,083 - $20,222	-259 Reduced 0.43%	60,313 $3.81 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $101,276 - $117,600	1,400 Added 2.37%	60,572 $4.66 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $237,179 - $303,793	-3,787 Reduced 6.02%	59,172 $4.42 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $71,848 - $79,031	-1,166 Reduced 1.82%	62,959 $4.09 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $128,333 - $141,657	-2,053 Reduced 3.1%	64,125 $4.06 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $9,280 - $10,407	150 Added 0.23%	66,178 $4.47 Million
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $298,393 - $334,278	-4,772 Reduced 6.74%	66,028 $4.29 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $104,613 - $136,512	-1,728 Reduced 2.38%	70,800 $4.43 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $106,920 - $118,380	-1,500 Reduced 2.03%	72,528 $5.6 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $487,508 - $568,659	7,514 Added 11.3%	74,028 $5.24 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $609,889 - $743,522	-8,373 Reduced 11.18%	66,514 $5.01 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $656,216 - $770,304	-9,223 Reduced 10.97%	74,887 $5.37 Million
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $6.17 Million - $7.31 Million	-85,541 Reduced 50.42%	84,110 $6.82 Million
Q2 2017 Aug 07, 2017	BUY	N/A	169,651	169,651 $12 Million

Others Institutions Holding GILD

# of Institutions

2,347

Shares Held

1.03B

Call Options Held

12.1M

Put Options Held

9.13M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $150B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollow Brook Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hollow Brook Wealth Management LLC with notifications on news.

Account

Hollow Brook Wealth Management LLC Gilead Sciences, Inc. Transaction History